Metagenomi director granted 21,000 stock options
Metagenomi Therapeutics, Inc. director Juergen Eckhardt received a grant of stock options covering 21,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Metagenomi Therapeutics, Inc. director Juergen Eckhardt received a grant of stock options covering 21,000 shares of common stock. The options have an exercise price of $1.23 per share and expire on June 8, 2036. They will vest and become exercisable on the earlier of the one-year anniversary of the grant date or the company's 2027 annual meeting of stockholders, subject to his continued service with the company. After this award, he holds 21,000 stock options directly.
Insider Trade Summary
Grant/Award: 21,000 shares
Grant/Award
1 txn
Insider
Eckhardt Juergen
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 21,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 21,000 contracts (Direct)
Footnotes (1)
- F1. The shares subject to this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the Grant Date or (ii) the date of the Company's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on such vesting date.
Key Figures
Stock options granted: 21,000 options
Exercise price: $1.23 per share
Underlying shares: 21,000 shares
+3 more
6 metrics
Stock options granted
21,000 options
Grant to director Juergen Eckhardt
Exercise price
$1.23 per share
Strike price for granted options
Underlying shares
21,000 shares
Common stock underlying the options
Post-grant option holdings
21,000 options
Total options held after this transaction
Option expiration date
June 8, 2036
Expiration of granted options
Vesting condition
Earlier of 1-year from grant or 2027 meeting
Subject to continued service
Key Terms
Stock Option (Right to Buy), exercise price, vesting, expiration date, +1 more
5 terms
Stock Option (Right to Buy) financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: 1.2300"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The shares subject to this option shall vest and become exercisable"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: 2036-06-08T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"underlying_security_title: Common Stock"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Metagenomi Therapeutics (MGX) report for Juergen Eckhardt?
Metagenomi Therapeutics reported that director Juergen Eckhardt received a grant of stock options for 21,000 shares of common stock. These options are part of his compensation and were not an open-market stock purchase or sale.
What is the exercise price of the new MGX stock options granted to Juergen Eckhardt?
The stock options granted to Juergen Eckhardt have an exercise price of $1.23 per share. This means he can buy Metagenomi Therapeutics common stock at $1.23 per share once the options vest and become exercisable.
When do Juergen Eckhardt’s Metagenomi Therapeutics (MGX) options vest?
The options will vest on the earlier of the one-year anniversary of the grant date or the company’s 2027 annual stockholders’ meeting. Vesting is conditioned on his continued service with Metagenomi Therapeutics through that date.
How many Metagenomi Therapeutics (MGX) options does Juergen Eckhardt hold after this grant?
After this grant, Juergen Eckhardt holds 21,000 stock options directly. Each option relates to one share of Metagenomi Therapeutics common stock, reflecting his full derivative position reported in this filing.
When do Juergen Eckhardt’s MGX stock options expire?
The granted stock options are scheduled to expire on June 8, 2036. If the options are not exercised by that expiration date after vesting, the right to buy Metagenomi Therapeutics shares at $1.23 per share will lapse.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates